“The dBA metric is, therefore, unsuited for evaluating airborne pressure waves occurring at frequencies below 800 Hz. Health effects that may be developing due to exposures at these lower frequencies cannot be properly studied if the dBA metric is being used to characterize acoustical environments.”

Acoustics and Biological Structures; By Mariana Alves-Pereira, Bruce Rapley, Huub Bakker & Rachel Summers.Submitted: August 7th 2018Reviewed: November 28th 2018Published: January 9th 2019 DOI: 10.5772/intechopen.82761
Abstract
Within the context of noise-induced health effects, the impact of airborne acoustical phenomena on biological tissues, particularly within the lower frequency ranges, is very poorly understood. Although the human body is a viscoelastic-composite material, it is generally modeled as Hooke elastic. This implies that acoustical coupling is considered to be nonexistent at acoustical frequencies outside of the human auditory threshold. Researching the acoustical properties of mammalian tissue raises many problems. When tissue samples are investigated as to their pure mechanical properties, stimuli are not usually in the form of airborne pressure waves. Moreover, since the response of biological tissue is dependent on frequency, amplitude, and time profile, precision laboratory equipment and relevant physiological endpoints are mandatory requirements that are oftentimes difficult to achieve. Drawing upon the viscoelastic nature of biological tissue and the tensegrity model of cellular architecture, this chapter will visit what is known to date on the biological response to a variety of different acoustic stimuli at very low frequencies.
Keywords
- infrasound
- low frequency noise
- health
- cellular biology
- tissue morphology
Open access. Each download brings research to wider audience.
Credit: 


[7] As described in greater detail below, the Approval Holder has proposed an amendment to the REA to include additional curtailment measures designed to reduce little brown myotis mortalities. The Tribunal finds that these additional measures, provided they are amended to require that they be implemented from sunset to sunrise, is likely to significantly reduce little brown myotis mortality over the life of the Project. However, as neither the Approval Holder nor the Director has proposed effective means to mitigate the serious harm to human health, as found by the Tribunal in its October 2016 Order, the Tribunal concludes that the decision of the Director should be revoked. As such, an amendment to the REA to address harm to little brown myotis via an amended mitigation plan is rendered unnecessary.
WE THOUGHT IT WAS OVER! TURBINE FIGHT STILL GOING! REMEDY HEARING FEB. 28TH!
By

